Annual Long Term Debt
$84.59 M
+$14.79 M+21.19%
31 December 2023
Summary:
Centessa Pharmaceuticals annual long term debt is currently $84.59 million, with the most recent change of +$14.79 million (+21.19%) on 31 December 2023. CNTA annual long term debt is now -74.22% below its all-time high of $328.06 million, reached on 01 June 2019.CNTA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$84.14 M
-$953.00 K-1.12%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly long term debt is currently $84.14 million, with the most recent change of -$953.00 thousand (-1.12%) on 30 September 2024. Over the past year, it has increased by +$1.12 million (+1.35%). CNTA quarterly long term debt is now -1.64% below its all-time high of $85.54 million, reached on 31 March 2024.CNTA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | +1.4% |
| 3 y3 years | - | - |
| 5 y5 years | -74.2% | - |
CNTA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +21.2% | -1.6% | +24.8% |
| 5 y | 5 years | -74.2% | +21.2% | -1.6% | >+9999.0% |
| alltime | all time | -74.2% | +21.2% | -1.6% | >+9999.0% |
Centessa Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $84.14 M(-1.1%) |
| June 2024 | - | $85.10 M(-0.5%) |
| Mar 2024 | - | $85.54 M(+1.1%) |
| Dec 2023 | $84.59 M(+21.2%) | $84.59 M(+1.9%) |
| Sept 2023 | - | $83.02 M(+0.7%) |
| June 2023 | - | $82.45 M(+1.9%) |
| Mar 2023 | - | $80.91 M(+15.9%) |
| Dec 2022 | $69.80 M | $69.80 M(+2.3%) |
| Sept 2022 | - | $68.20 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $67.40 M(-9.9%) |
| Mar 2022 | - | $74.80 M(-1.2%) |
| Dec 2021 | $75.70 M(-75.6%) | $75.70 M(>+9900.0%) |
| Mar 2021 | - | $291.00 K |
| June 2020 | $310.85 M(-5.2%) | - |
| June 2019 | $328.06 M(+52.4%) | - |
| June 2018 | $215.23 M(-17.6%) | - |
| June 2017 | $261.24 M(-10.3%) | - |
| June 2016 | $291.39 M(+50.9%) | - |
| June 2015 | $193.09 M | - |
FAQ
- What is Centessa Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual long term debt year-on-year change?
- What is Centessa Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly long term debt year-on-year change?
What is Centessa Pharmaceuticals annual long term debt?
The current annual long term debt of CNTA is $84.59 M
What is the all time high annual long term debt for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual long term debt is $328.06 M
What is Centessa Pharmaceuticals annual long term debt year-on-year change?
Over the past year, CNTA annual long term debt has changed by +$14.79 M (+21.19%)
What is Centessa Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of CNTA is $84.14 M
What is the all time high quarterly long term debt for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly long term debt is $85.54 M
What is Centessa Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, CNTA quarterly long term debt has changed by +$1.12 M (+1.35%)